The influence of high-normal thyreostimulating hormone and subclinical hypothyroidism on risk profile of patients with manifest coronary heart disease

被引：0
|
作者：
Mayer, O
Rosolova, SH
Pikner, R
Holubec, L
Hrbkova, J
机构：
[1] Univ Hosp, Dept Immunodiagnost, Plzen, Czech Republic
[2] Charles Univ, Ctr Prevent Cardiol, Dept Internal Med 2, Fac Med, CR-11636 Prague 1, Czech Republic
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [41] Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease
    Grandi, Norma Christine
    Breitling, Lutz Philipp
    Hahmann, Harry
    Wuesten, Bernd
    Maerz, Winfried
    Rothenbacher, Dietrich
    Brenner, Hermann
    HEART, 2011, 97 (15) : 1215 - 1221
  • [42] Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.
    Cannon, Christopher P.
    Shah, Sukrut
    Dansky, Hayes M.
    Davidson, Michael
    Brinton, Eliot A.
    Gotto, Antonio M., Jr.
    Stepanavage, Michael
    Liu, Sherry Xueyu
    Gibbons, Patrice
    Ashraf, Tanya B.
    Zafarino, Jennifer
    Mitchel, Yale
    Barter, Philip
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25): : 2406 - 2415
  • [43] Is There a High-Risk Subtype of Depression in Patients with Coronary Heart Disease?
    Robert M. Carney
    Kenneth E. Freedland
    Current Psychiatry Reports, 2012, 14 : 1 - 7
  • [44] Attainment of cholesterol guidelines in patients at high risk for coronary heart disease
    Dobard, MD
    Brouse, SD
    Shah, MJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (03) : 212 - +
  • [45] Influence of hormone replacement therapy (HRT) on lipids risk factors for coronary heart disease (CHD)
    Zamaklar-Trifunovic, DD
    Zamaklar, M
    Lalic, K
    Kapor, S
    Simeunovic, D
    Seferovic, PM
    Ristic, AD
    Trifunovic, B
    ATHEROSCLEROSIS, 1999, 144 : 101 - 101
  • [46] EFFECTIVENESS OF CORONARY HEART-DISEASE RISK MANAGEMENT IN HIGH-RISK PATIENTS
    LEITHA, T
    STAUDENHERZ, A
    BACHMANN, B
    DUDCZAK, R
    CLINICAL CARDIOLOGY, 1994, 17 (03) : 123 - 130
  • [47] Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population
    Blumenthal, RS
    Becker, DM
    Moy, TF
    Coresh, J
    Wilder, LB
    Becker, LC
    CIRCULATION, 1996, 93 (05) : 915 - 923
  • [48] HIGH-FREQUENCY COMPONENTS IN ELECTROCARDIOGRAMS OF NORMAL SUBJECTS AND OF PATIENTS WITH CORONARY HEART DISEASE
    LANGNER, PH
    MANSURE, FT
    GESELOWITZ, DB
    AMERICAN HEART JOURNAL, 1961, 62 (06) : 746 - &
  • [49] Cholesterol treatment levels in high risk patients for coronary heart disease.
    Ball, B
    Hopkins, PN
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 90A - 90A
  • [50] Comparison of the coronary heart disease risk factor profile of risperidone vs olanzapine treated patients
    Bouchard, RH
    Villeneuve, J
    Alméras, N
    Simoneau, I
    Demers, MF
    Cadrin, C
    Roy, MA
    Mottard, JP
    Després, JP
    EUROPEAN PSYCHIATRY, 2000, 15 : 382S - 383S
12345